NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2020 pay jumps 103% to $1.1M
NEUROONE MEDICAL TECHNOLOGIES Corp reports 2020 executive compensation
By ExecPay News
Published: May 6, 2021
NEUROONE MEDICAL TECHNOLOGIES Corp reported fiscal year 2020 executive compensation information on May 6, 2021.
In 2020, three executives at NEUROONE MEDICAL TECHNOLOGIES Corp received on average a compensation package of $562K, a 52% increase compared to previous year.
Average pay of disclosed executives at NEUROONE MEDICAL TECHNOLOGIES Corp
Dave Rosa, Chief Executive Officer, received $1.1M in total, which increased by 103% compared to 2019. 48% of Rosa's compensation, or $547K, was in option awards. Rosa also received $183K in non-equity incentive plan and $404K in salary.
Steve Mertens, Chief Technology Officer, received a compensation package of $291K, which is about the same as previous year. 82% of the compensation package, or $239K, was in salary.
Mark Christianson, Business Development Director, Medical Sales Liaison, earned $261K in 2020, a 1% increase compared to previous year.
NEUROONE MEDICAL TECHNOLOGIES Corp's fiscal year ends on September 30.
Related executives
You may also like
Source: SEC filing on May 6, 2021.